The recommended dosage of EPIVIR in HIV-1‑infected adults is 300 mg daily, administered as either 150 mg taken orally twice daily or 300 mg taken orally once daily with or without food
It's available as Epivir to treat human immunodeficiency virus (HIV) infections and Epivir HBV to treat hepatitis B virus (HBV)
The recommended dosage of COMBIVIR in HIV‑1‑infected adults and adolescents weighing greater than or equal to 30 kg is 1 tablet (containing 150 mg of lamivudine and 300 mg of zidovudine) taken orally twice daily
EPIVIR oral solution is for oral administration
HIV-1 infection, treatment (Epivir): Treatment of HIV-1 in combination with other antiretroviral agents
HIV-1 resistance may emerge in chronic hepatitis B patients with unrecognized or untreated HIV-1 infection because the lamivudine dosage in EPIVIR‑HBV is subtherapeutic and Each tablet contains 100 mg of lamivudine and the inactive ingredients hypromellose, macrogol 400, magnesium stearate, microcrystalline cellulose, polysorbate 80, red iron oxide, sodium starch glycolate, titanium dioxide, and yellow iron oxide
Adult 150 mg every 12 hours, alternatively 300 mg once daily
The following trial was conducted with the individual components of abacavir and lamivudine tablets
Indications and Usage
EPIVIR ® (lamivudine) TABLETS
EPIVIR Tablets are for oral administration
Know it’s uses, side effects, reviews, composition and precautions only on 1mg
Lamivudine is an antiviral medication
Epivir is used to treat HIV (human immunodeficiency virus) infection in adults and children